New capsule shows promise in brain cancer fight
Disease control
Not yet recruiting
This study tests whether adding NG101m capsules to standard chemoradiation helps people with newly diagnosed glioblastoma live longer. About 52 adults will receive NG101m alongside usual care. The main goals are to check safety and see if 2-year survival improves.
Phase: PHASE1, PHASE2 • Sponsor: NeuGATE Theranostics • Aim: Disease control
Last updated Jun 15, 2026 19:05 UTC